News

2024

company

year

domain

Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer

Quotient Therapeutics 08.28.2024

Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner

08.06.2024

GSK and Flagship Pioneering partner to discover novel medicines and vaccines

07.29.2024

Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World

07.25.2024

Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class

Abiologics 07.23.2024

Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability

07.10.2024

Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions

07.10.2024

KSQ Therapeutics Announces First Patient Dosed in Clinical Development Program for KSQ-001EX, a CRISPR/Cas9 Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy

KSQ Therapeutics 06.12.2024

Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer

ProFound™ Therapeutics 06.12.2024

Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management

Metaphore Biotechnologies 05.09.2024

Loading